1 – 2 of 2 jobs
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
BIDDING INSTRUCTIONS Technical Proposal Bidders shall submit a proposal clearly providing the following information: Understanding and experience within NATO More than 7 years of NATO experience related to Education and Training. Previous experience at the NATO
